486 related articles for article (PubMed ID: 28638161)
1. Argatroban for Heparin-Induced Thrombocytopenia during Venovenous Extracorporeal Membrane Oxygenation with Continuous Venovenous Hemofiltration.
Sin JH; Lopez ND
J Extra Corpor Technol; 2017 Jun; 49(2):115-120. PubMed ID: 28638161
[TBL] [Abstract][Full Text] [Related]
2. Argatroban in adult extracorporeal membrane oxygenation.
Johnston N; Wait M; Huber L
J Extra Corpor Technol; 2002 Dec; 34(4):281-4. PubMed ID: 12533066
[TBL] [Abstract][Full Text] [Related]
3. Heparin-induced thrombocytopenia in a pediatric patient receiving extracorporeal support and treated with argatroban.
Scott LK; Grier LR; Conrad SA
Pediatr Crit Care Med; 2006 May; 7(3):255-7. PubMed ID: 16474254
[TBL] [Abstract][Full Text] [Related]
4. Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study.
Fisser C; Winkler M; Malfertheiner MV; Philipp A; Foltan M; Lunz D; Zeman F; Maier LS; Lubnow M; Müller T
Crit Care; 2021 Apr; 25(1):160. PubMed ID: 33910609
[TBL] [Abstract][Full Text] [Related]
5. Bivalirudin in venovenous extracorporeal membrane oxygenation.
Jyoti A; Maheshwari A; Daniel E; Motihar A; Bhathiwal RS; Sharma D
J Extra Corpor Technol; 2014 Mar; 46(1):94-7. PubMed ID: 24779126
[TBL] [Abstract][Full Text] [Related]
6. Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support: Review of the literature and alternative anticoagulants.
Pollak U
J Thromb Haemost; 2019 Oct; 17(10):1608-1622. PubMed ID: 31313454
[TBL] [Abstract][Full Text] [Related]
7. Suspected Heparin-Induced Thrombocytopenia in Patients Receiving Extracorporeal Membrane Oxygenation.
Natt B; Hypes C; Basken R; Malo J; Kazui T; Mosier J
J Extra Corpor Technol; 2017 Mar; 49(1):54-58. PubMed ID: 28298667
[TBL] [Abstract][Full Text] [Related]
8. The dosing and monitoring of argatroban for heparin-induced thrombocytopenia during extracorporeal membrane oxygenation: a word of caution.
Phillips MR; Khoury AI; Ashton RF; Cairns BA; Charles AG
Anaesth Intensive Care; 2014 Jan; 42(1):97-8. PubMed ID: 24471670
[TBL] [Abstract][Full Text] [Related]
9. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.
Pieri M; Agracheva N; Bonaveglio E; Greco T; De Bonis M; Covello RD; Zangrillo A; Pappalardo F
J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):30-4. PubMed ID: 23036625
[TBL] [Abstract][Full Text] [Related]
10. Argatroban in extracorporeal membrane oxygenation.
Beiderlinden M; Treschan T; Görlinger K; Peters J
Artif Organs; 2007 Jun; 31(6):461-5. PubMed ID: 17537058
[TBL] [Abstract][Full Text] [Related]
11. An infrequent complication of a not so infrequent disease. Hit by HIT.
Sandoval E; Ascaso M; Quintana E; Pereda D
Asian Cardiovasc Thorac Ann; 2019 Feb; 27(2):124-126. PubMed ID: 30011999
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal membrane oxygenation bridging to lung transplant complicated by heparin-induced thrombocytopenia.
Dolch ME; Frey L; Hatz R; Uberfuhr PA; Beiras-Fernandez A; Behr J; Irlbeck M; Lung Transplant Group TM
Exp Clin Transplant; 2010 Dec; 8(4):329-32. PubMed ID: 21143102
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin.
Rivosecchi RM; Arakelians AR; Ryan J; Murray H; Ramanan R; Gomez H; Phillips D; Sciortino C; Arlia P; Freeman D; Sappington PL; Sanchez PG
Crit Care Med; 2021 Jul; 49(7):1129-1136. PubMed ID: 33711003
[TBL] [Abstract][Full Text] [Related]
14. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
Krueger K; Schmutz A; Zieger B; Kalbhenn J
Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
[TBL] [Abstract][Full Text] [Related]
15. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
Dager WE; White RH
Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
[TBL] [Abstract][Full Text] [Related]
16. Lung transplantation using argatroban in severe heparin-induced thrombocytopenia during extracorporeal membrane oxygenation: a case series.
Lee SK; Cho WH; Kim DH; Yeo HJ
Gen Thorac Cardiovasc Surg; 2020 Dec; 68(12):1565-1568. PubMed ID: 32266702
[TBL] [Abstract][Full Text] [Related]
17. Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support in pediatric patients: review of the literature and alternative anticoagulants.
Pollak U
Perfusion; 2018 May; 33(1_suppl):7-17. PubMed ID: 29788841
[TBL] [Abstract][Full Text] [Related]
18. Argatroban usage for anticoagulation for ECMO on a post-cardiac patient with heparin-induced thrombocytopenia.
Mejak B; Giacomuzzi C; Heller E; You X; Ungerleider R; Shen I; Boshkov L
J Extra Corpor Technol; 2004 Jun; 36(2):178-81. PubMed ID: 15334762
[TBL] [Abstract][Full Text] [Related]
19. Use of argatroban for extracorporeal life support in patients with nonheparin-induced thrombocytopenia: Analysis of 10 consecutive patients.
Kim YS; Lee H; Yang JH; Sung K; Suh GY; Chung CR; Yang JH; Cho YH
Medicine (Baltimore); 2018 Nov; 97(47):e13235. PubMed ID: 30461625
[TBL] [Abstract][Full Text] [Related]
20. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation.
Dager WE; Gosselin RC; Yoshikawa R; Owings JT
Ann Pharmacother; 2004 Apr; 38(4):598-601. PubMed ID: 14982973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
